LICENSE AGREEMENTLicense Agreement • May 25th, 2018 • Cannapowder, Inc. • Pharmaceutical preparations
Contract Type FiledMay 25th, 2018 Company IndustryYISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM, LTD., of Hi Tech Park, Edmond J. Safra Campus, Givat Ram, Jerusalem 91390, Israel (“Yissum”), of the first part; and CANNA POWDER LTD, of 20 Raul Wallenberg, Tel Aviv, Israel (the “Company”), of the second part; (each of Yissum and the Company, a “Party”, and collectively the “Parties”)
Confidential portions have been omitted pursuant to a request for confidential treatment and have been filed separately with the Securities and Exchange Commission (the “Commission”)** LICENSE AGREEMENTLicense Agreement • May 1st, 2017 • Therapix Biosciences Ltd. • Pharmaceutical preparations
Contract Type FiledMay 1st, 2017 Company IndustryThis Research and License Agreement (“Agreement”) is made in Jerusalem this 30th day of March 2017 (the “Effective Date”), by and between: